Clinical |

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Firstwordpharma News - July 18, 2020

Pharma Industry News and Analysis - FirstWord Pharma - Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Firstwordpharma News - July 18, 2020

Pharma Industry News and Analysis - FirstWord Pharma - Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Firstwordpharma News - July 18, 2020

Pharma Industry News and Analysis - FirstWord Pharma - Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Firstwordpharma News - July 18, 2020

Pharma Industry News and Analysis - FirstWord Pharma - Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Firstwordpharma News - July 18, 2020

Pharma Industry News and Analysis - FirstWord Pharma - Benefits

12 3...322 Page 1 of 322

LATEST NEWS

ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States

Firstwordpharma News - June 13, 2019

Vaccibody AS and Nektar Therapeutics Present New Preclinical Data from their Immuno-Oncology Collaboration at the American Association for Cancer Research (AACR) Annual Meeting 2019

April 1, 2019

Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment

October 21, 2019

MUST READ

Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives –...

Firstwordpharma News - March 24, 2020

Sigilon Therapeutics Announces $80.3 Million Series B Financing to Advance Shielded Living Therapeutics to...

Firstwordpharma News - March 18, 2020

InDex Pharmaceuticals Holding AB (publ) Year end Report 2018

Biospace News - February 20, 2019

Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…

Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…

BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…

X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…

BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…

Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…

Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…

Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma

Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…

Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…

BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…

Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…

Clinical

BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China – FirstWord Pharma

Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor) Research – FirstWord Pharma

Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa – FirstWord Pharma

Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

Pharma Industry News and Analysis – FirstWord Pharma – Benefits

LATEST NEWS

ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States

Vaccibody AS and Nektar Therapeutics Present New Preclinical Data from their Immuno-Oncology Collaboration at the American Association for Cancer Research (AACR) Annual Meeting 2019

Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment

MUST READ

Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives –...

Sigilon Therapeutics Announces $80.3 Million Series B Financing to Advance Shielded Living Therapeutics to...

InDex Pharmaceuticals Holding AB (publ) Year end Report 2018

POPULAR POSTS

United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial...

Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial...

Ocular Therapeutix Announces FDA Approval of Supplemental New Drug Application (sNDA)...

POPULAR CATEGORY